Pharmaceutical Portfolio

 Chemic Laboratories' Synthetic Chemistry & Discovery Business Unit, with more than 15 years of experience in the field of compound development, has announced the launch of an API portfolio. With our collection approaching 400 compounds in numerous indication categories, Chemic Laboratories is now aggressively seeking out “Industry Partners” to jointly move select compounds further along the drug development pipeline.

Novel Permeation Enhancers

Contact us

Anhydroleucovorin

Polydocanol Lactate

Indocyanine Green

Client Sponsor B (TBD)

37 Compound POC Study

in Progress